Li et al. [37] found that ginsenoside Rg1 reduced microglial activation and mitochondrial dysfunction, thereby alleviating depression-like behavior through the GAS5/EZH2/SOCS3/NRF2 axis. Here, SOCS3 is linked to major depressive disorder.